Actinium Pharmaceuticals (ATNM)
(Real Time Quote from BATS)
$6.55 USD
-0.01 (-0.15%)
Updated Apr 26, 2024 10:02 AM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/20/24 |
---|---|
Current Quarter | -0.42 |
EPS Last Quarter | -0.33 |
Last EPS Surprise | 38.89% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.87 |
Next Year | 0.97 |
EPS (TTM) | -1.83 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 96.35M |
# of Estimates | NA | NA | NA | 2 |
High Estimate | NA | NA | NA | 141.30M |
Low Estimate | NA | NA | NA | 51.40M |
Year ago Sales | 0.00M | 0.00M | 0.08M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.42 | -0.46 | -1.87 | 0.97 |
# of Estimates | 1 | 1 | 3 | 1 |
Most Recent Consensus | -0.42 | -0.46 | -1.84 | 0.97 |
High Estimate | -0.42 | -0.46 | -1.82 | 0.97 |
Low Estimate | -0.42 | -0.46 | -1.94 | 0.97 |
Year ago EPS | -0.43 | -0.58 | -1.83 | -1.87 |
Year over Year Growth Est. | 2.33% | 20.69% | -2.19% | 151.70% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 1 | 0 |
Down Last 60 Days | 0 | 0 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.42 | -0.46 | -1.87 | 0.97 |
7 Days Ago | -0.42 | -0.46 | -1.87 | 0.97 |
30 Days Ago | NA | NA | -1.81 | 0.87 |
60 Days Ago | NA | NA | -1.81 | 0.87 |
90 Days Ago | NA | NA | -1.81 | 0.87 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.42 | -0.46 | -1.89 | 0.97 |
Zacks Consensus Estimate | -0.42 | -0.46 | -1.87 | 0.97 |
Earnings ESP | 0.00% | 0.00% | -1.25% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.33 | -0.49 | -0.58 | -0.43 | NA |
Estimate | -0.54 | NA | -0.50 | -0.42 | NA |
Difference | 0.21 | NA | -0.08 | -0.01 | 0.04 |
Surprise | 38.89% | NA | -16.00% | -2.38% | 6.84% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more